No Data
No Data
Poseida Therapeutics to Be Acquired by Roche Holdings in $1.5 Billion Deal
Roche's Lung-Cancer Trial Failure Doesn't Surprise -- Market Talk
Roche's Genentech Provides Update On SKYSCRAPER-01 Phase III Study In PD-L1-High NSCLC Patients
Poseida Therapeutics To Be Acquired BB Roche In $1.5B Deal, Stockholders To Receive Up To $13/ Share In Cash
Roche: Transaction Is Expected Closed in 1Q 2025
Roche: Stockholders Would Also Get a Non-Tradeable Contingent Value Right
72713902 : isn't lkm a subsidiary of lumiradx?
Ryand83 OP 72713902 : yes, but that will most likely be what Roche uses then again they could rename it Roche related
73497473 : Roche Diagnostics UK .